The Accountant Shortage Is Showing Up in Financial Statements

Advance Auto Parts and others have cited a lack of skilled accounting personnel for material weaknesses…

FDA’s OK Isn’t Always a Happy Day for Biotech Investors

In recent weeks, three FDA rulings were positive for the companies — after which their stocks…

FDA’s OK Isn’t Always a Happy Day for Biotech Investors

In recent weeks, three FDA rulings were positive for the companies — after which their stocks…

Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts

Ozempic is under review by European drug-safety regulators after reports of suicidal thoughts were linked to…

In Battle With Microsoft, Google Bets on Medical AI Program to Crack Healthcare Industry

The search giant is driving chatbot technology through medical licensing exams.

The Job Market vs. Inflation

The Federal Reserve’s rate hike hasn’t hurt the job market or inflation as much as investors…

Obesity Drugs Won’t Starve These Other Potential Blockbusters

Shares of developers of fatty liver disease treatments were in decline until Eli Lilly published results…

FDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patients

The agency’s full approval may result in people enrolled in Medicare receiving anti-amyloid treatment.

WSJ News Exclusive | Tyson Foods to Drop ‘No Antibiotics Ever’ Label on Some Chicken Products

The move would cover drugs that are not critical to human health and would apply to…

Grantham Warns AI Boom Won’t Prevent Market Bubble From Bursting

Money manager GMO, co-founded by Jeremy Grantham, bets on cheap stocks and bonds backed by commercial…